M. Schulze

发表

Successful treatment of PLA2R1-antibody positive membranous nephropathy with ocrelizumab

S. Harendza, E. Hoxha, Tilman Schmidt, 2020, Journal of Nephrology.

Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study

P. Fornara, G. Theil, Stefan Heim, 2022, World Journal of Urology.

Identification of Four Mouse Diabetes Candidate Genes Altering β-Cell Proliferation

H. Vogel, A. Schürmann, H. Joost, 2015, PLoS genetics.

DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.

E. Thiel, W. Hofmann, D. Hoelzer, 2007, Experimental hematology.

Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC)

L. Horn, J. Stolzenburg, J. Neuhaus, 2012, World Journal of Urology.

Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS).

Kurt Miller, Hartwig Huland, Andrea Tubaro, 2015, European urology.

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan

J. Huebner, H. Heinzer, M. Baier, 2014, Cancer Microenvironment.

Redirecting and Modulating Rationalizations of Tumor-Immanent Normative Functions in Castration-Resistant Prostate Cancer

J. Huebner, H. Heinzer, M. Baier, 2013 .

Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.

A. Stenzl, M. Wirth, K. Miller, 2012, The Canadian journal of urology.

Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.

E. Thiel, W. Hofmann, D. Hoelzer, 2009, Leukemia research.

NADIR: A Non-Interventional Study on the Prophylaxis of Chemotherapy-Induced Neutropenia Using Lipegfilgrastim - First Interim Analysis

H. Tesch, C. Salat, P. Klare, 2015, Oncology Research and Treatment.

Baseline and On-Treatment Markers Determining Prognosis of First-Line Chemotherapy in Combination with Bevacizumab in Patients with Metastatic Colorectal Cancer

A. Stein, D. Arnold, V. Petersen, 2017, Oncology Research and Treatment.

A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC).

M. Baier, R. Andreesen, A. Reichle, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Final analysis of a non-interventional study on cabozantinib in patients with advanced renal cell carcinoma after prior checkpoint inhibitor therapy (CaboCHECK).

V. Grünwald, G. Niegisch, M. Maasberg, 2022, Journal of Clinical Oncology.

[What do urologist do in daily practice? : A first "unfiltered" look at patient care].

P. Goebell, M. Horstmann, T. Quack, 2021, Der Urologe. Ausg. A.

Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.

E. Thiel, W. Hofmann, D. Hoelzer, 2009, Leukemia research.